These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16239581)

  • 1. Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis.
    Barousse MM; Espinosa T; Dunlap K; Fidel PL
    Infect Immun; 2005 Nov; 73(11):7765-7. PubMed ID: 16239581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of Candida albicans by human vaginal epithelial cells.
    Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
    J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to Candida.
    Fidel PL
    Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of Candida albicans by vaginal cells from naïve mice.
    Steele C; Ozenci H; Luo W; Scott M; Fidel PL
    Med Mycol; 1999 Aug; 37(4):251-9. PubMed ID: 10421860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congenital anti-candida of human vaginal epithelial cells].
    Liu Zh; Chen L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):174-7. PubMed ID: 18458694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.
    Fidel PL; Barousse M; Espinosa T; Ficarra M; Sturtevant J; Martin DH; Quayle AJ; Dunlap K
    Infect Immun; 2004 May; 72(5):2939-46. PubMed ID: 15102806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History and update on host defense against vaginal candidiasis.
    Fidel PL
    Am J Reprod Immunol; 2007 Jan; 57(1):2-12. PubMed ID: 17156186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity in vaginal candidiasis.
    Fidel PL
    Curr Opin Infect Dis; 2005 Apr; 18(2):107-11. PubMed ID: 15735412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of Lactobacillus as protector against vaginal candidiasis].
    Osset J; García E; Bartolomé RM; Andreu A
    Med Clin (Barc); 2001 Sep; 117(8):285-8. PubMed ID: 11571120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the production of IgG derived from vaginal epithelial cells and the effect of anti-Candida albicans].
    Niu XX; Li T; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Oct; 51(10):739-744. PubMed ID: 27788740
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes.
    Black CA; Eyers FM; Russell A; Dunkley ML; Clancy RL; Beagley KW
    J Reprod Immunol; 1999 Nov; 45(1):1-18. PubMed ID: 10660259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scanning electron microscopic observation of interactions of vaginal epithelial cells with Candida albicans and Lactobacillus crispatus].
    Zhang X; Li T; Niu XX; Wang SX; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2017 Sep; 52(9):618-622. PubMed ID: 28954451
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.
    Yano J; Noverr MC; Fidel PL
    Cytokine; 2012 Apr; 58(1):118-28. PubMed ID: 22182685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis.
    Schaller M; Korting HC; Borelli C; Hamm G; Hube B
    Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.
    Fidel PL; Ginsburg KA; Cutright JL; Wolf NA; Leaman D; Dunlap K; Sobel JD
    J Infect Dis; 1997 Sep; 176(3):728-39. PubMed ID: 9291322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal and oral epithelial cell anti-Candida activity.
    Nomanbhoy F; Steele C; Yano J; Fidel PL
    Infect Immun; 2002 Dec; 70(12):7081-8. PubMed ID: 12438389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal Epithelial Cells Discriminate Between Yeast and Hyphae of Candida albicans in Women Who Are Colonized or Have Vaginal Candidiasis.
    Roselletti E; Perito S; Sabbatini S; Monari C; Vecchiarelli A
    J Infect Dis; 2019 Oct; 220(10):1645-1654. PubMed ID: 31300818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.
    Yano J; Lilly EA; Steele C; Fortenberry D; Fidel PL
    Oral Microbiol Immunol; 2005 Aug; 20(4):199-205. PubMed ID: 15943762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal candidiasis: review and role of local mucosal immunity.
    Fidel PL
    AIDS Patient Care STDS; 1998 May; 12(5):359-66. PubMed ID: 11361971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.